Bristol-Myers Squibb Co (NYSE:BMY) over-valued by 31%
| Website | https://www.bms.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $146,362,662,912 |
| Beta | 0.619786 |
| Average Volume | $11,550,316 |
| Last Dividend | 1.88% |
| Price on Feb 9, 2022 | $72.41 |
| Autochartist™ Valuation | $50.25 |
| Conclusion |
31% over-valued |
| Download Report |
